Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma

BACKGROUND: Thalidomide maintenance therapy after stem cell transplantation resulted in increased progression-free survival and overall survival in a few trials, but its role in non-transplant eligible patients with multiple myeloma remains unclear. This study assessed the impact of thalidomide-inte...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ludwig, Heinz, Adam, Zdenek, Tóthová, Elena, Hajek, Roman, Labar, Boris, Egyed, Miklós, Spicka, Ivan, Gisslinger, Heinz, Drach, Johannes, Kuhn, Ingrid, Hinke, Axel, Zojer, Niklas
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2010
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2930957/
https://ncbi.nlm.nih.gov/pubmed/20418244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.020586
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars